Femara and malignant neoplasm progression Patient Reports February 10, 2012

Femara Side Effects Report #5898014-8
Femara side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 21, 2008. Female patient, 60 years of age, was diagnosed with neoplasm malignant and was treated with Femara. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Femara dosage: 2.5 MG, QD. During the same period patient was treated with ZOMETA. Patient died on 03/11/2008.

Femara Side Effects Report #6064105-4
Femara side effect was reported by a Health Professional from UNITED STATES on Feb 03, 2009. Female patient, weighting 197.0 lb, was diagnosed with breast disorder and was treated with Femara. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, microangiopathic haemolytic anaemia, no therapeutic response, thrombotic thrombocytopenic purpura. Femara dosage: 2.5 MG PO QD. During the same period patient was treated with TARCEVA. Patient was hospitalized. Patient recovered.

Femara Side Effects Report #4635274-5
Femara side effect was reported by a Consumer or non-health professional from on Apr 04, 2005. Female patient, 52 years of age, was diagnosed with breast cancer stage iv and was treated with Femara. After drug was administered, patient experienced the following side effects: agitation, blood thyroid stimulating hormone increased, cough, heart rate increased, insomnia, malignant neoplasm progression. Femara dosage: unknown. Patient recovered.

Femara Side Effects Report #4638041-1
Femara side effect was reported by a Consumer or non-health professional from on Apr 04, 2005. Female patient, 52 years of age, was diagnosed with breast cancer stage iv and was treated with Femara. After drug was administered, patient experienced the following side effects: agitation, arrhythmia , blood thyroid stimulating hormone increased, cough, dyspnoea, heart rate increased, insomnia, malignant neoplasm progression, platelet count decreased. Femara dosage: unknown. During the same period patient was treated with ZOMETA. Patient recovered.


Femara Side Effects Report #4685314-2
Femara side effect was reported by a Consumer or non-health professional from on Apr 04, 2005. Female patient, 52 years of age, was diagnosed with breast cancer stage iv and was treated with Femara. After drug was administered, patient experienced the following side effects: agitation, arrhythmia , blood thyroid stimulating hormone increased, cough, dyspnoea, heart rate increased, insomnia, malignant neoplasm progression, platelet count decreased. Femara dosage: unknown. During the same period patient was treated with ZOMETA. Patient recovered.

Femara Side Effects Report #4558549-7
Femara side effect was reported by a Physician from on Jan 19, 2005. Female patient was diagnosed with breast cancer stage iv and was treated with Femara. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, stevens-johnson syndrome. Femara dosage: 2.5 MG/DAY. Patient died.

Femara Side Effects Report #5215568-5
Femara side effect was reported by a Physician from UNITED KINGDOM on Jan 12, 2007. Female patient, 59 years of age, was diagnosed with breast cancer metastatic and was treated with Femara. After drug was administered, patient experienced the following side effects: atelectasis, dyspnoea, life support, lung disorder, malignant neoplasm progression, oedema peripheral, pleural effusion, wheezing. Femara dosage: 2.5 MG, QD. During the same period patient was treated with ADVAIR DISKUS. Patient was hospitalized. Patient recovered.

Femara Side Effects Report #5234236-7
Femara side effect was reported by a Physician from UNITED KINGDOM on Jan 26, 2007. Female patient, 59 years of age, was diagnosed with breast cancer metastatic and was treated with Femara. After drug was administered, patient experienced the following side effects: atelectasis, dyspnoea, life support, lung disorder, malignant neoplasm progression, oedema peripheral, pleural effusion, wheezing. Femara dosage: 2.5 MG, QD. During the same period patient was treated with ADVAIR DISKUS, FLUTICASONE W. Patient was hospitalized. Patient recovered.

Femara Side Effects Report #5234243-4
Femara side effect was reported by a Physician from UNITED KINGDOM on Jan 26, 2007. Female patient, 59 years of age, was diagnosed with breast cancer metastatic and was treated with Femara. After drug was administered, patient experienced the following side effects: atelectasis, dyspnoea, life support, lung disorder, malignant neoplasm progression, oedema peripheral, pleural effusion, wheezing. Femara dosage: 2.5 MG, QD. During the same period patient was treated with ADVAIR DISKUS, FLUTICASONE W. Patient was hospitalized. Patient recovered.


Femara Side Effects Report #4970302-9
Femara side effect was reported by a Physician from GERMANY on Dec 13, 2005. Female patient, 58 years of age, weighting 280.0 lb, was diagnosed with breast cancer metastatic and was treated with Femara. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, myocardial infarction. Femara dosage: 2.5 MG, QD. Patient died on 12/01/2005.

Femara Side Effects Report #5152852-8
Femara side effect was reported by a Physician from UNITED STATES on Feb 17, 2006. Female patient, 46 years of age, weighting 196.9 lb, was diagnosed with breast cancer metastatic and was treated with Femara. After drug was administered, patient experienced the following side effects: biopsy lymph gland, malignant breast lump removal, malignant neoplasm progression. Femara dosage: 2.5 MG, QD, ORAL. During the same period patient was treated with VITAMIN D. Patient recovered.

Femara Side Effects Report #4860905-4
Femara side effect was reported by a Physician from GERMANY on Dec 13, 2005. Female patient was diagnosed with breast cancer metastatic and was treated with Femara. After drug was administered, patient experienced the following side effects: breast cancer metastatic, malignant neoplasm progression, myocardial infarction. Femara dosage: 2.5 MG, QD. Patient died on 12/01/2005.

Femara Side Effects Report #5089009-5
Femara side effect was reported by a Consumer or non-health professional from MEXICO on Aug 21, 2006. Female patient, 87 years of age, was diagnosed with breast cancer  and was treated with Femara. After drug was administered, patient experienced the following side effects: femur fracture, hip fracture, malignant neoplasm progression, metastases to bone, renal failure. Femara dosage: 2.5 MG/D. During the same period patient was treated with TRADOL, RIVOTRIL, ANALGESICS. Patient was hospitalized. Patient died on 08/15/2006.

Femara Side Effects Report #5152850-4
Femara side effect was reported by a Physician from UNITED STATES on Apr 06, 2006. Female patient, 82 years of age, weighting 155.0 lb, was diagnosed with breast cancer  and was treated with Femara. After drug was administered, patient experienced the following side effects: abdominal pain lower, malignant neoplasm progression, osteolysis. Femara dosage: 2.5 MG, QD, ORAL. Patient recovered.


Femara Side Effects Report #5443071-6
Femara side effect was reported by a Physician from GERMANY on Sept 03, 2007. Female patient, 81 years of age, weighting 143.3 lb, was diagnosed with breast cancer  and was treated with Femara. After drug was administered, patient experienced the following side effects: condition aggravated, malignant neoplasm progression, metastases to liver, metastases to lung, osteoporosis , ultrasound scan. Femara dosage: unknown. During the same period patient was treated with ALENDRONIC ACID, VITAMIN D, CALCIUM. Patient recovered.

Femara Side Effects Report #5474024-X
Femara side effect was reported by a Physician from GERMANY on Sept 21, 2007. Female patient, 81 years of age, weighting 143.3 lb, was diagnosed with breast cancer  and was treated with Femara. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, metastases to liver, metastases to lung, ultrasound scan. Femara dosage: unknown. During the same period patient was treated with ALENDRONIC ACID, VITAMIN D, CALCIUM. Patient recovered.

Femara Side Effects Report #4960321-0
Femara side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 22, 2006. Female patient, 71 years of age, was diagnosed with breast cancer  and was treated with Femara. After drug was administered, patient experienced the following side effects: aspiration biopsy, malignant breast lump removal, malignant neoplasm progression. Femara dosage: 2.5 MG, QD. Patient recovered.

Femara Side Effects Report #4967746-8
Femara side effect was reported by a Physician from UNITED STATES on Mar 22, 2006. Female patient, 71 years of age, weighting 256.9 lb, was diagnosed with breast cancer  and was treated with Femara. After drug was administered, patient experienced the following side effects: aspiration biopsy, bronchitis chronic, discomfort, malignant breast lump removal, malignant neoplasm progression, metastases to lymph nodes, oedema peripheral, stent placement. Femara dosage: 2.5 MG, QD. During the same period patient was treated with ANSAID, ZYRTEC, LOPRESSOR, LISINOPRIL, LASIX, PAXIL, PULMICORT, SPIRIVA. Patient recovered.

Femara Side Effects Report #6106126-9
Femara side effect was reported by a Physician from SOUTH AFRICA on Mar 04, 2009. Female patient, 65 years of age, was diagnosed with breast cancer , disease progression and was treated with Femara. After drug was administered, patient experienced the following side effects: breast cancer recurrent, malignant neoplasm progression. Femara dosage: 2.5 MG, FOR 4 YEARS. Patient died.


Femara Side Effects Report #6115567-5
Femara side effect was reported by a Physician from SOUTH AFRICA on Mar 11, 2009. Female patient, 65 years of age, was diagnosed with breast cancer , disease progression and was treated with Femara. After drug was administered, patient experienced the following side effects: breast cancer recurrent, malignant neoplasm progression. Femara dosage: 2.5 MG, FOR 4 YEARS. Patient died.

Femara Side Effects Report #5164219-7
Femara side effect was reported by a Health Professional from UNITED STATES on Dec 05, 2005. Female patient, 49 years of age, was diagnosed with breast cancer  and was treated with Femara. After drug was administered, patient experienced the following side effects: breast disorder, carbohydrate antigen 15-3, chest wall mass, malignant neoplasm progression. Femara dosage: 2.5 MG, QD, ORAL. Patient recovered.

Femara Side Effects Report #5224914-8
Femara side effect was reported by a Physician from JAPAN on Jan 10, 2007. Female patient, 46 years of age, weighting 83.78 lb, was diagnosed with breast cancer  and was treated with Femara. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, malignant neoplasm progression, metastases to bone, metastases to liver, metastases to lung, oral intake reduced. Femara dosage: 2.5 MG, QD. During the same period patient was treated with DUROTEP JANSSEN, LOXONIN, MARZULENE S, NAPROXEN, NAVELBINE, ARIMIDEX. Patient died on 10/09/2006.

Femara Side Effects Report #4666188-2
Femara side effect was reported by a Consumer or non-health professional from on May 10, 2005. Female patient, 43 years of age, was diagnosed with breast cancer  and was treated with Femara. After drug was administered, patient experienced the following side effects: abdominal distension, back pain , malignant neoplasm progression, metastases to ovary, metrorrhagia, oophorectomy, scan abnormal. Femara dosage: 2.5 MG, QD. During the same period patient was treated with FEMHRT. Patient recovered.

Femara Side Effects Report #4674317-X
Femara side effect was reported by a Consumer or non-health professional from on May 10, 2005. Female patient, 43 years of age, was diagnosed with breast cancer  and was treated with Femara. After drug was administered, patient experienced the following side effects: abdominal distension, back pain , malignant neoplasm progression, metastases to ovary, metrorrhagia, oophorectomy, positron emission tomogram abnormal. Femara dosage: 2.5 MG, QD. During the same period patient was treated with FEMHRT. Patient recovered.


Femara Side Effects Report #5476511-7
Femara side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 13, 2007. Female patient, 42 years of age, was diagnosed with breast cancer  and was treated with Femara. After drug was administered, patient experienced the following side effects: arthralgia, malignant neoplasm progression, oestradiol increased, plantar fasciitis, tendonitis, trigger finger, vulvovaginal dryness. Femara dosage: 2.5 MG, QD, ORAL. Patient recovered.

Femara Side Effects Report #5970996-5
Femara side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 24, 2008. Female patient was diagnosed with breast cancer  and was treated with Femara. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Femara dosage: 2.5 MG, QD. During the same period patient was treated with GABAPENTIN, MEGACE, LIPITOR, MECLIZINE, NEURONTIN, FENTANYL, ZOLOFT, MORPHINE. Patient died on 11/25/2008.

Femara Side Effects Report #5980311-9
Femara side effect was reported by a Health Professional from UNITED STATES on Dec 03, 2008. Female patient, weighting 101.5 lb, was diagnosed with breast cancer  and was treated with Femara. After drug was administered, patient experienced the following side effects: arm amputation, breast cancer metastatic, hepatic neoplasm malignant, infection , malignant neoplasm progression. Femara dosage: 2.5 MG, QD. During the same period patient was treated with ANTINEOPLASTIC AGENTS. Patient was hospitalized. Patient died on 10/01/2008.

Femara Side Effects Report #6035653-8
Femara side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 09, 2009. Female patient was diagnosed with breast cancer  and was treated with Femara. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, pneumonia . Femara dosage: 2.5 MG, QD. Patient died on 10/14/2008.

Femara Side Effects Report #6075797-8
Femara side effect was reported by a Physician from UNITED STATES on Feb 11, 2009. Female patient was diagnosed with breast cancer  and was treated with Femara. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, pneumonia . Femara dosage: 2.5 MG, QD. Patient died on 10/14/2008.


Femara Side Effects Report #6088855-9
Femara side effect was reported by a Health Professional from UNITED STATES on Feb 16, 2009. Female patient, weighting 180.0 lb, was diagnosed with breast cancer  and was treated with Femara. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, metastases to bone, metastases to lung, productive cough, wheezing. Femara dosage: 2.5 MG, QD. During the same period patient was treated with TAXOTERE, ABRAXANE, ADRIAMYCIN PFS. Patient recovered.

Femara Side Effects Report #6099871-5
Femara side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 26, 2009. Female patient was diagnosed with breast cancer  and was treated with Femara. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, pneumonia . Femara dosage: 2.5 MG, QD. Patient died on 10/14/2008.

Femara Side Effects Report #6102990-8
Femara side effect was reported by a Health Professional from UNITED STATES on Feb 24, 2009. Female patient, weighting 180.0 lb, was diagnosed with breast cancer  and was treated with Femara. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, metastases to bone, metastases to lung, productive cough, upper respiratory tract infection, wheezing. Femara dosage: 2.5 MG, QD. During the same period patient was treated with TAXOTERE, ABRAXANE, ADRIAMYCIN PFS. Patient recovered.